FindTrial
Sign In

An observational single centre study to devolep a pictorial tool to predict and avoid unnecessary Surgery in gallbladder Cancer.

Development of a novel predictive nomogram to prevent futile surgery in gallbladder cancers a single center analysis of resected gallbladder cancers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093468
Enrollment
1126
Registered
2025-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: nil

Sponsors

Tata Memorial Hospital, Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients with histopathology proven gallbladder adenocarcinoma (GBAC) 2. All GBC patients who underwent a curative resection at Tata Memorial Hospital, Parel.

Exclusion criteria

Exclusion criteria: 1. Patients with other GBC pathologies such as neuroendocrine, sarcomatoid or hepatoid as well as benign pathologies. 2. Macroscopic positive (R2) resections or inoperable disease on surgical exploration

Design outcomes

Primary

MeasureTime frame
to develop a nomogram to predict possibility of ?futile surgery? in gallbladder cancersTimepoint: 12 months from the study start date—

Secondary

MeasureTime frame
To assess disease-free survival, defined as the time from surgery to recurrence or death, will be evaluated.Timepoint: 12 months from the study start date;To assess the overall survival.Timepoint: 12 months from the study start date—

Countries

India

Contacts

Public ContactDr Shraddha Patkar

Tata Memorial Hospital, Mumbai

drshraddhapatkar@gmail.com9820074818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026